... cancer and rare diseases, is one of two biotechs slated to go public next week, according to Renaissance Capital. Shelton, Conn.-based Cara Therapeutics, which is developing a novel opioid pain medication, also hopes to hold an IPO next week in what ...
via Shelton Newswire http://ift.tt/1iuEaQg
via Shelton Newswire http://ift.tt/1iuEaQg
No comments:
Post a Comment